Cargando…
A V530I Mutation in c-KIT Exon 10 Is Associated to Imatinib Response in Extraabdominal Aggressive Fibromatosis
Aggressive fibromatosis (AF) or desmoid tumor is a rare condition, characterized by deep tissue invasion by a monoclonal fibroblastic neoplasm, developed from musculoaponeurotic structures. Surgery is the treatment of choice, but negative margins can hardly been achieved in large tumors, and can lea...
Autores principales: | Kurtz, Jean-Emmanuel, Asmane, Irène, Voegeli, Anne-Claire, Neuville, Agnès, Dufresne, Armelle, Litique, Valère, Chevreau, Christine, Bergerat, Jean-Pierre |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2841250/ https://www.ncbi.nlm.nih.gov/pubmed/20339585 http://dx.doi.org/10.1155/2010/458156 |
Ejemplares similares
-
Extraabdominal fibromatosis in retroperitoneal space
por: Kikkawa, Akira, et al.
Publicado: (2004) -
Diagnosis and treatment of extraabdominal desmoid fibromatosis
por: Ghanem, Mohamed, et al.
Publicado: (2014) -
Impact of KIT exon 10 M541L allelic variant on the response to imatinib in aggressive fibromatosis: analysis of the desminib series by competitive allele specific Taqman PCR technology
por: Dufresne, Armelle, et al.
Publicado: (2014) -
Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis
por: Dufresne, A, et al.
Publicado: (2010) -
Extraabdominal parasitic lipoleiomyoma
por: Lee, Tae Hoon, et al.
Publicado: (2021)